Prognostic Impact of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Coronary Ischemia: A Retrospective Cohort Study
SGLT2 inhibitors were found to be associated with a reduced risk of 3-year MACE and all-cause mortality in patients with T2DM and coronary ischemia, regardless of extent of revascularization.
Authors
- Henry Lik‐Yuen Chan (ORCID: https://orcid.org/0000-0002-7790-1611)
- Ran Guo (ORCID: https://orcid.org/0000-0003-0654-6314)
- Jiayi Huang (ORCID: https://orcid.org/0000-0003-1783-8195)
- Haochen Xuan (ORCID: https://orcid.org/0000-0002-2017-9285)
- Tongda Xu (ORCID: https://orcid.org/0000-0002-5594-3992)
- Gaozhen Cao (ORCID: https://orcid.org/0000-0002-1150-4146)
- Jingnan Zhang (ORCID: https://orcid.org/0000-0002-4865-5212)
- Calvin Ka-Lam Leung
- Kai-Hang Yiu (ORCID: https://orcid.org/0000-0003-2145-3108)
- Run Wang (ORCID: https://orcid.org/0000-0002-6635-4093)
- Wenli Gu (ORCID: https://orcid.org/0000-0002-9964-8805)
- Qingwen Ren
- Yik‐Ming Hung
Institutions
- Xuzhou Medical College (CN)
- Queen Mary Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Diabetes & Metabolism Journal
- Published
- 2025-10-24
- DOI
- https://doi.org/10.4093/dmj.2025.0200
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Sanming Project of Medicine in Shenzhen